| 1 |
35001794 | The urinary exosomes derived from premature infants attenuate cisplatin-induced acute kidney injury in mice via microRNA-30a-5p/ mitogen-activated protein kinase 8 (MAPK8). | 2022 Jan |
2 |
| 2 |
35179434 | Circ_0067934 reduces JNK phosphorylation through a microRNA-545-3p/PPA1 axis to enhance tumorigenesis and cisplatin resistance in ovarian cancer. | 2022 Apr |
1 |
| 3 |
35236965 | STAMBPL1 promotes breast cancer cell resistance to cisplatin partially by stabilizing MKP-1 expression. | 2022 Apr |
2 |
| 4 |
35251480 | Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress. | 2022 |
2 |
| 5 |
35578316 | SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer. | 2022 May 16 |
1 |
| 6 |
33456714 | Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals. | 2021 Jan 5 |
1 |
| 7 |
33460665 | RIPK1 contributes to cisplatin-induced apoptosis of esophageal squamous cell carcinoma cells via activation of JNK pathway. | 2021 Mar 15 |
1 |
| 8 |
33921192 | Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro. | 2021 Apr 12 |
1 |
| 9 |
33959604 | Isoalantolactone Increases the Sensitivity of Prostate Cancer Cells to Cisplatin Treatment by Inducing Oxidative Stress. | 2021 |
1 |
| 10 |
33973461 | The new-generation proteasome inhibitor oprozomib increases the sensitivity of cervical cancer cells to cisplatin-induced apoptosis. | 2021 Mar-Apr |
1 |
| 11 |
33990641 | trans-Fatty acids promote p53-dependent apoptosis triggered by cisplatin-induced DNA interstrand crosslinks via the Nox-RIP1-ASK1-MAPK pathway. | 2021 May 14 |
1 |
| 12 |
34274415 | Cisplatin induces autophagy-associated apoptosis in human oral squamous cell carcinoma (OSCC) mediated in part through reactive oxygen species. | 2021 Sep 15 |
1 |
| 13 |
34306367 | CHOP overexpression sensitizes human non-small cell lung cancer cells to cisplatin treatment by Bcl-2/JNK pathway. | 2021 |
3 |
| 14 |
34533242 | Rosamultin from Potentilla anserine L. exhibits nephroprotection and antioxidant activity by regulating the reactive oxygen species/C/EBP homologous protein signaling pathway. | 2021 Nov |
1 |
| 15 |
34790784 | TRPA1 promotes cisplatin-induced nephrotoxicity through inflammation mediated by the MAPK/NF-κB signaling pathway. | 2021 Oct |
1 |
| 16 |
32238696 | Pro-apoptotic functions of TRAF2 in p53-mediated apoptosis induced by cisplatin. | 2020 |
2 |
| 17 |
32277442 | A comparative molecular analysis of DNA damage response, cell cycle progression, viability and apoptosis of malignant granulosa cells exposed to gemcitabine and cisplatin. | 2020 May |
1 |
| 18 |
32308804 | Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma. | 2020 |
1 |
| 19 |
32341033 | DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN-WEE1 Signaling. | 2020 Jul 15 |
1 |
| 20 |
32533982 | Enhanced expression of lncRNA ZXF1 promotes cisplatin resistance in lung cancer cell via MAPK axis. | 2020 Oct |
1 |
| 21 |
32695207 | Ginsenoside Rh1 Alleviates HK-2 Apoptosis by Inhibiting ROS and the JNK/p53 Pathways. | 2020 |
1 |
| 22 |
32781170 | Hydroxytyrosol enhances cisplatin-induced ototoxicity: Possible relation to the alteration in the activity of JNK and AIF pathways. | 2020 Nov 15 |
1 |
| 23 |
32884297 | MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway. | 2020 |
4 |
| 24 |
33072762 | Isodeoxyelephantopin Inactivates Thioredoxin Reductase 1 and Activates ROS-Mediated JNK Signaling Pathway to Exacerbate Cisplatin Effectiveness in Human Colon Cancer Cells. | 2020 |
1 |
| 25 |
30614075 | Core fucosylation of copper transporter 1 plays a crucial role in cisplatin-resistance of epithelial ovarian cancer by regulating drug uptake. | 2019 May |
1 |
| 26 |
30868675 | Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells. | 2019 May |
3 |
| 27 |
30922965 | PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway. | 2019 Apr |
1 |
| 28 |
31056532 | MiR-124 sensitizes cisplatin-induced cytotoxicity against CD133+ hepatocellular carcinoma cells by targeting SIRT1/ROS/JNK pathway. | 2019 May 5 |
2 |
| 29 |
31176737 | Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS. | 2019 Sep |
2 |
| 30 |
31929796 | Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based Chemotherapy. | 2019 |
2 |
| 31 |
29071589 | Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK/Parkin/mitophagy axis. | 2018 Jan |
1 |
| 32 |
29103194 | Astragalus polysaccharides increase the sensitivity of SKOV3 cells to cisplatin. | 2018 Feb |
1 |
| 33 |
29393335 | Schizandrin B inhibits the cis‑DDP‑induced apoptosis of HK‑2 cells by activating ERK/NF‑κB signaling to regulate the expression of survivin. | 2018 Apr |
2 |
| 34 |
29432736 | miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin. | 2018 Mar 11 |
2 |
| 35 |
29458150 | PINK1 Protects Auditory Hair Cells and Spiral Ganglion Neurons from Cisplatin-induced Ototoxicity via Inducing Autophagy and Inhibiting JNK Signaling Pathway. | 2018 May 20 |
1 |
| 36 |
29512740 | Programmed cell death 4 overexpression enhances sensitivity to cisplatin via the JNK/c-Jun signaling pathway in bladder cancer. | 2018 May |
2 |
| 37 |
29940575 | Knockdown of MiR-20a Enhances Sensitivity of Colorectal Cancer Cells to Cisplatin by Increasing ASK1 Expression. | 2018 |
2 |
| 38 |
30032449 | Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation. | 2018 Oct |
1 |
| 39 |
28232663 | cAMP signaling increases histone deacetylase 8 expression via the Epac2-Rap1A-Akt pathway in H1299 lung cancer cells. | 2017 Feb 24 |
1 |
| 40 |
28287190 | NLRX1 accelerates cisplatin-induced ototoxity in HEI-OC1 cells via promoting generation of ROS and activation of JNK signaling pathway. | 2017 Mar 13 |
3 |
| 41 |
28597042 | Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells. | 2017 Aug |
3 |
| 42 |
28598976 | The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells. | 2017 |
1 |
| 43 |
28650468 | MKP-1 suppresses PARP-1 degradation to mediate cisplatin resistance. | 2017 Oct 26 |
1 |
| 44 |
28886730 | Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells. | 2017 Sep 8 |
2 |
| 45 |
29033791 | Protein Synthesis Inhibition and Activation of the c-Jun N-Terminal Kinase Are Potential Contributors to Cisplatin Ototoxicity. | 2017 |
3 |
| 46 |
29039558 | Insulin in combination with cisplatin induces the apoptosis of ovarian cancer cells via p53 and JNK activation. | 2017 Dec |
1 |
| 47 |
26534836 | Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel. | 2016 Jan |
4 |
| 48 |
27193727 | Fenofibrate reduces cisplatin-induced apoptosis of renal proximal tubular cells via inhibition of JNK and p38 pathways. | 2016 |
5 |
| 49 |
27313779 | P53 Is Involved in a Three-Dimensional Architecture-Mediated Decrease in Chemosensitivity in Colon Cancer. | 2016 |
3 |
| 50 |
27374471 | C-Jun N-terminal kinase signalling pathway in response to cisplatin. | 2016 Nov |
4 |